Business · 30/10/2015Updated: 10/17/2026 · 1 min read

FDA Announces Stay of Guidance on Human Research Studies Without IND Applications

The Food and Drug Administration (FDA) has temporarily suspended certain portions of its guidance for clinical investigators, sponsors, and institutional review boards regarding human research studies that do not require an Investigational New Drug Application (IND).